Joshua Brody, MD

4:10

Drs. Josh Brody and Nathan Fowler discuss strategies to combine checkpoint inhibition and CAR T cell therapy to achieve deep remissions in relapsed/refractory lymphoma patients where checkpoint inhibition alone has thus far been unsuccessful